Counting the costs of MS

By  

Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Counting the Costs of Drug-Related Adverse Events

By White T.J.  

PharmacoEconomics, Vol. 15, Iss. 5, 1999-05 ,pp. : 445-458

Adis International

Access to resources Recommend Favorite

Counting costs of diabetes? Better start early . . .

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 583, 2009-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Application of In-Line Liquid Chromatography-Accurate Radioisotope Counting-Mass Spectrometry (LC-ARC-MS) to Evaluate Metabolic Profile of [3H]-Mefenamic Acid in Rat Plasma

By  

Drug Metabolism Letters, Vol. 1, Iss. 3, 2007-08 ,pp. : 179-188

Bentham Science Publishers

Access to resources Recommend Favorite

A decision by Spanish Health Minister Ms Ana Pastor to decrease costs of drug spending within the country's NHS has added to pressure already felt by drug manufacturers

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 404, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite